ATR and Miyoshi myopathy: Along similar lines, in a more clinically relevant setting, the combination of ATR inhibition with VX-670/M6620 and the alkylating agent melphalan, one of the key drugs used in MM chemotherapy, was strongly synergistic, both in vitro and in vivo [53].